Kraig Biocraft Laboratories Inc (KBLB)

[Corner Pocket]

I agree with you. Anytime you see a change in auditors, it normally (99% of the time) has to do with an accounting position that may have been misinterpreted or misapplied. Sometimes it is better for both parties to walk away from each other than make a big deal about it.

The substance behind FAS 133 is to prevent companies from issuing substantially discounted shares without recognizing the associated expenditure which comes in the form of massive dilution. It appears to me that FAS 133 applies to both CSC transactions and KBLB may have understated its expense by millions and millions for every put.

We will see how the new auditors deal with this issue. I still don't understand the missing 8K.